Condition (MeSH)
Fasciitis, Necrotizing
ClinicalTrials.gov lists 28 trials for Fasciitis, Necrotizing or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
28 of the 28 trials are tagged with Fasciitis, Necrotizing itself; the rest are tagged with a narrower condition beneath it.
When did Fasciitis, Necrotizing trials start? (14)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 3 |
| 2023 | 2 |
| 2021 | 3 |
| 2020 | 3 |
| 2017 | 1 |
| 2015 | 1 |
| 2014 | 2 |
| 2013 | 5 |
| 2012 | 1 |
Showing 10 of 14 earlier years.
No forecast is made for this condition: it averages 1.8 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fasciitis, Necrotizing trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 9 |
| Observational | 16 |
How many Fasciitis, Necrotizing trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 3 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Completed | 15 |
| Terminated | 1 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Fasciitis, Necrotizing trials? (3)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Atox Bio Ltd | 1 |
| Avita Medical | 1 |
| Kerecis Ltd. | 1 |
Which drugs are being tested for Fasciitis, Necrotizing? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Daptomycin | 1 |
| Honey | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Hyperbaric Oxygen | 2 |
| NaCl 0.9% NS | 1 |
| Indocyanine Green dye | 1 |
| AB103 0.5 mg/kg | 1 |
| IVIG | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Fasciitis, Necrotizing trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac arrest | 8 | 1 |
| Acute kidney injury | 6 | 1 |
| Acute respiratory distress syndrome | 6 | 1 |
| Necrotizing soft tissue infection | 6 | 1 |
| Acute myocardial infarction | 5 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Fasciitis, Necrotizing? (36)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Vacuum-assisted closure versus conventional dressing in necrotizing fasciitis: a systematic review and meta-analysis. | Journal of orthopaedic surgery and research | 2023 | Yes |
| Duration of Antibiotic Therapy in Necrotizing Soft Tissue Infections: Shorter is Safe. | Surgical infections | 2022 | Yes |
| Estimating the Impact of Necrotizing Soft Tissue Infections in the United States: Incidence and Re-Admissions. | Surgical infections | 2021 | Yes |
| Correlation Between Immunoglobulin Dose Administered and Plasma Neutralization of Streptococcal Superantigens in Patients With Necrotizing Soft Tissue Infections. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020 | Yes |
| Necrotizing skin and soft-tissue infections in the intensive care unit. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2020 | Yes |
Showing 5 of 36 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence, rare-disease identity, and sub-conditions in mesh.